Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 3
1984 2
1985 2
1986 1
1990 1
1993 1
1994 2
1995 3
1996 1
1997 3
1998 1
1999 1
2000 2
2001 3
2002 2
2003 1
2004 1
2010 2
2011 3
2012 2
2013 4
2014 6
2015 1
2016 4
2018 2
2019 5
2020 4
2021 7
2022 3
2023 7
2024 5
2025 7
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.
Cui C, Wang J, Fagerberg E, Chen PM, Connolly KA, Damo M, Cheung JF, Mao T, Askari AS, Chen S, Fitzgerald B, Foster GG, Eisenbarth SC, Zhao H, Craft J, Joshi NS. Cui C, et al. Cell. 2021 Dec 9;184(25):6101-6118.e13. doi: 10.1016/j.cell.2021.11.007. Epub 2021 Nov 30. Cell. 2021. PMID: 34852236 Free PMC article.
CD4 T follicular helper (TFH) cells support B cells, which are critical for germinal center (GC) formation, but the importance of TFH-B cell interactions in cancer is unclear. ...Development of TFH cells requires B cells and B cell-recognized neoantige …
CD4 T follicular helper (TFH) cells support B cells, which are critical for germinal center (GC) formation, but the importance of TFH …
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diabetes Collaborators. GBD 2021 Diabetes Collaborators. Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22. Lancet. 2023. PMID: 37356446 Free PMC article.
At the super-region level, the highest age-standardised rates were observed in north Africa and the Middle East (9.3% [8.7-9.9]) and, at the regional level, in Oceania (12.3% [11.5-13.0]). Nationally, Qatar had the world's highest age-specific prevalence of diabetes, at 76 …
At the super-region level, the highest age-standardised rates were observed in north Africa and the Middle East (9.3% [8.7-9.9]) and, at the …
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators. GBD 2021 Diseases and Injuries Collaborators. Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
Immunization.
McDonnell WM, Askari FK. McDonnell WM, et al. JAMA. 1997 Dec 10;278(22):2000-7. JAMA. 1997. PMID: 9396663 Review.
Vaccines made of DNA are being developed as a form of gene therapy that use the patient's own cellular machinery to make foreign proteins that stimulate an immune response. ...New technologies are being investigated to induce the immune system to fight infections that have …
Vaccines made of DNA are being developed as a form of gene therapy that use the patient's own cellular machinery to make foreign prot …
Genetically modified immune cells targeting tumor antigens.
Poorebrahim M, Abazari MF, Sadeghi S, Mahmoudi R, Kheirollahi A, Askari H, Wickström SL, Poortahmasebi V, Lundqvist A, Kiessling R, Cid-Arregui A. Poorebrahim M, et al. Pharmacol Ther. 2020 Oct;214:107603. doi: 10.1016/j.pharmthera.2020.107603. Epub 2020 Jun 15. Pharmacol Ther. 2020. PMID: 32553789 Free article. Review.
Waldenstrom's Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell Malignancy.
Askari E, Rodriguez S, Garcia-Sanz R. Askari E, et al. J Blood Med. 2021 Aug 30;12:795-807. doi: 10.2147/JBM.S267938. eCollection 2021. J Blood Med. 2021. PMID: 34512060 Free PMC article. Review.
The diagnosis requires the presence of a monoclonal IgM component and bone marrow lymphoid infiltration must be demonstrated. In addition, other small B-cell lymphoid neoplasms with plasma cell differentiation must be discarded. Although the clinical picture is highly hete …
The diagnosis requires the presence of a monoclonal IgM component and bone marrow lymphoid infiltration must be demonstrated. In addition, o …
Hepatitis B among University Population: Prevalence, Associated Risk Factors, Knowledge Assessment, and Treatment Management.
Kazmi SA, Rauf A, Alshahrani MM, Awadh AAA, Iqbal Z, Soltane R, Tag-Eldin E, Ahmad A, Ansari Z, Zia-Ur-Rehman. Kazmi SA, et al. Viruses. 2022 Aug 31;14(9):1936. doi: 10.3390/v14091936. Viruses. 2022. PMID: 36146743 Free PMC article.
Background: Very few studies have been reported on hepatitis B in the State of Azad Jammu and Kashmir, Pakistan, and none of them are specific to the prevalence and causes of hepatitis B spread among educational institutes. ...A questionnaire and interview method wa …
Background: Very few studies have been reported on hepatitis B in the State of Azad Jammu and Kashmir, Pakistan, and none of them are …
A review on the role of LINC00472 in malignant and non-malignant disorders.
Ghafouri-Fard S, Askari A, Hussen BM, Rasul MF, Taheri M, Ayatollahi SA. Ghafouri-Fard S, et al. Pathol Res Pract. 2023 Jul;247:154549. doi: 10.1016/j.prp.2023.154549. Epub 2023 May 18. Pathol Res Pract. 2023. PMID: 37235910 Free article. Review.
Increasing our understanding of LINC00472's crucial roles will open new doors for creating effective therapeutic approaches against cancer and related diseases. ...
Increasing our understanding of LINC00472's crucial roles will open new doors for creating effective therapeutic approaches against c …
Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
Bagheri V, Askari A, Arababadi MK, Kennedy D. Bagheri V, et al. Hum Immunol. 2014 Jun;75(6):549-54. doi: 10.1016/j.humimm.2014.02.018. Epub 2014 Feb 12. Hum Immunol. 2014. PMID: 24530748 Review.
The current literature describes pivotal mechanisms in which hepatitis B virus (HBV) induces liver diseases including inflammation, cirrhosis and hepatocellular carcinoma (HCC). ...Therefore, defective TLR2 expression may result in impaired immune responses against HBV whi …
The current literature describes pivotal mechanisms in which hepatitis B virus (HBV) induces liver diseases including inflammation, c …
85 results